Carasent ASA Stock Nasdaq Stockholm
Stocks
CARAO
NO0010123060
Advanced Medical Equipment & Technology
OTC Markets Traded| Market Cap | 1.64B 171M 149M 139M 127M 241M 16.29B 244M 1.63B 639M 8.14B 643M 629M 26.98B | P/E 2026 * |
71.9x | P/E 2027 * | 28.6x |
|---|---|---|---|---|---|
| Enterprise Value | 1.64B 172M 149M 139M 128M 242M 16.35B 244M 1.64B 641M 8.17B 645M 631M 27.08B | EV / Sales 2026 * |
3.87x | EV / Sales 2027 * | 3.03x |
| Free-Float |
65.26% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Carasent ASA
| 1 day | -3.90% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.90% | -54.08% | - | - | 171M | |
| +2.72% | +5.30% | -25.74% | +7.59% | 34.42B | |
| +4.99% | +10.68% | -42.64% | +155.46% | 12.7B | |
| +0.30% | -3.66% | -23.59% | +65.31% | 5.43B | |
| +1.94% | +6.60% | - | - | 2.35B | |
| -0.42% | +8.68% | - | - | 1.83B | |
| -1.33% | -13.70% | +22.12% | -42.83% | 1.69B | |
| +0.07% | +5.22% | -33.68% | - | 1.06B | |
| +1.38% | +0.23% | +32.34% | +106.54% | 873M | |
| +2.78% | +10.12% | -37.71% | -48.68% | 849M | |
| Average | +0.93% | +2.67% | -15.56% | +40.56% | 6.8B | |
| Weighted average by Cap. | +2.67% | +4.25% | -27.31% | +45.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 424M 44.42M 38.57M 35.96M 33.04M 62.48M 4.23B 63.17M 424M 166M 2.11B 167M 163M 7B | 516M 54.01M 46.9M 43.72M 40.17M 75.97M 5.14B 76.8M 516M 202M 2.57B 203M 198M 8.51B |
| Net income | 24.2M 2.53M 2.2M 2.05M 1.88M 3.56M 241M 3.6M 24.18M 9.45M 120M 9.51M 9.3M 399M | 60.96M 6.38M 5.54M 5.17M 4.75M 8.98M 607M 9.07M 60.9M 23.81M 303M 23.96M 23.44M 1.01B |
| Net Debt | 5.87M 615K 534K 498K 457K 865K 58.48M 874K 5.87M 2.29M 29.23M 2.31M 2.26M 96.87M | -73.31M -7.67M -6.66M -6.21M -5.71M -10.79M -730M -10.91M -73.25M -28.63M -365M -28.82M -28.19M -1.21B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
